Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000664861 | SCV000788882 | uncertain significance | Autosomal recessive DOPA responsive dystonia | 2017-01-09 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000761754 | SCV000891941 | uncertain significance | not provided | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000664861 | SCV000896138 | uncertain significance | Autosomal recessive DOPA responsive dystonia | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000664861 | SCV001006505 | benign | Autosomal recessive DOPA responsive dystonia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000664861 | SCV001262250 | uncertain significance | Autosomal recessive DOPA responsive dystonia | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Natera, |
RCV000664861 | SCV001463815 | benign | Autosomal recessive DOPA responsive dystonia | 2020-09-16 | no assertion criteria provided | clinical testing |